About Nippon Boehringer Ingelheim Co., Ltd
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Nippon Boehringer Ingelheim Co., Ltd
During the past decade, Nippon Boehringer Ingelheim Co., Ltd conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on
average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Nippon Boehringer Ingelheim Co., Ltd"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nippon Boehringer Ingelheim Co., Ltd
According to Clinical.Site data, the most researched conditions in "Nippon Boehringer Ingelheim Co., Ltd" are
"Atrial Fibrillation" (3 trials), "Hypertension" (2 trials), "Lung Diseases, Interstitial" (2 trials), "Asthma" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Nippon Boehringer Ingelheim Co., Ltd" in a lesser frequency.
Clinical Trials Intervention Types at Nippon Boehringer Ingelheim Co., Ltd
Most popular intervention types in "Nippon Boehringer Ingelheim Co., Ltd" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Nintedanib" (2 trials), "Apixaban" (1 trials), "Dabigatran" (1 trials), "Edoxaban" (1 trials) and "JARDIANCE®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nippon Boehringer Ingelheim Co., Ltd
The vast majority of trials in "Nippon Boehringer Ingelheim Co., Ltd" are
11 trials for "All" genders.
Clinical Trials Status at Nippon Boehringer Ingelheim Co., Ltd
Currently, there are NaN active trials in "Nippon Boehringer Ingelheim Co., Ltd".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Nippon Boehringer Ingelheim Co., Ltd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nippon Boehringer Ingelheim Co., Ltd, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".